AARDVARK THERAPEUTICS INC (AARD) Stock Analyst Earnings Estimates
NASDAQ:AARD - Nasdaq - US0029421007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 2,312.03% | ||||
| EBITDA YoY % growth | -10.253M | -7.318M 28.63% | -22.769M -211.14% | N/A -187.78% | N/A -29.12% | N/A -19.20% | |
| EBIT YoY % growth | -10.363M | -7.415M 28.45% | -22.785M -207.28% | N/A -195.68% | N/A -22.23% | N/A -47.11% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -0.55% | N/A -7.42% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.61 | -0.73 | -0.76 | -0.79 -10.62% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.082M -95.08% | -17.204M -237.94% | -18.404M -94.75% | -19.89M -89.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.71 | -0.69 | -0.02 | -3.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 11.76% | 15.09% | 6.68% | -4.19% |
| Revenue | N/A | N/A | N/A | N/A |